JAK inhibitor therapy for myelofibrosis: Critical assessment of value and limitations

A. Pardanani, A. M. Vannucchi, F. Passamonti, F. Cervantes, T. Barbui, A. Tefferi

Research output: Contribution to journalReview articlepeer-review

94 Scopus citations

Fingerprint Dive into the research topics of 'JAK inhibitor therapy for myelofibrosis: Critical assessment of value and limitations'. Together they form a unique fingerprint.

Medicine & Life Sciences